Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8485762 | Vaccine | 2018 | 9 Pages |
Abstract
Herpes simplex virus is a prevalent pathogen of humans of various age groups. The fact that no prophylactic or therapeutic vaccine is currently available suggests a significant need to further investigate the immune mechanisms induced by the virus and various vaccine candidates. We previously generated an HSV-1 mutant strain, M3, with partial deletions in ul7, ul41 and LAT that produced an attenuated phenotype in mice. In the present study, we performed a comparative analysis to characterize the immune responses induced by M3 versus wild-type HSV-1 in a mouse model. Infection with wild-type HSV-1 triggered an inflammatory-dominated response and adaptive immunity suppression and was accompanied by severe pathological damage. In contrast, infection with M3 induced a systematic immune response involving full activation of both innate and adaptive immunity and was accompanied by no obvious pathological changes. Furthermore, the immune response induced by M3 protected mice from lethal challenge with wild-type strains of HSV-1 and restrained virus proliferation and impaired latency. These data are useful for further HSV-1 vaccine development using a mutant strain construction strategy.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Xiaolong Zhang, Quanlong Jiang, Xingli Xu, Yongrong Wang, Lei Liu, Yaru Lian, Hao Li, Lichun Wang, Ying Zhang, Guorun Jiang, Jieyuan Zeng, Han Zhang, Jing-Dong Jackie Han, Qihan Li,